呼和浩特治肛瘘哪里好呼和浩特市痔疮便血如何治疗,呼和浩特肠镜痛苦吗,呼市去哪里看便血好,呼市混合痔微创手术多少钱,呼和浩特脱肛治疗费用大概多少,清水河县超好肛肠医院,赛罕区极大肛肠医院

WASHINGTON, May 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Sutent to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body.Neuroendocrine tumors found in the pancreas are slow-growing and rare. It is estimated that there are fewer than 1,000 new cases in the United States each year.This is the second new approval by the FDA to treat patients with this disease. On May 5, the agency approved Afinitor."FDA believes it is important to provide cancer patients with as many treatment options as possible," said Richard Pazdur, director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research. "The agency is committed to working with companies to bring innovative new therapies to the market and encourages companies to continue exploring additional uses for approved products."The safety and effectiveness of Sutent was established in a single study of 171 patients with metastatic (late-stage) or locally advanced (disease that could not be removed with surgery) disease who received Sutent or a placebo (sugar pill). The study was designed to measure the length of time a patient lived before their disease spread or worsened (progression-free survival).Results from the study demonstrate that Sutent provided benefit to patients by prolonging the median length of time they lived without the cancer spreading or worsening to 10.2 months compared to 5.4 months for patients who received placebo.In patients treated with Sutent for neuroendocrine pancreatic tumors, the most commonly reported side effects included diarrhea, nausea, vomiting, fatigue, anorexia, high blood pressure, energy loss, stomach pain, changes in hair color, inflammation of the mouth, and a decrease in infection-fighting white blood cells.Sutent is marketed by New York City-based Pfizer.

SAN FRANCISCO, May 10 (Xinhua) -- Google on Tuesday launched its long-awaited cloud-based music service Music Beta without any label licenses it originally wanted.The search giant introduced the digital music locker service at its annual I/O developer conference in San Francisco. So far, only U.S. users can access the service by requesting an invitation from Google while priorities will be given to those with the Verizon version of the Motorola Xoom tablet and attendees of the I/O conference.Since Google failed to come to a license agreement with major music labels, Music Beta is essentially a massive cloud hard drive. Users cannot share their Music Beta by Google tunes or purchase new songs. It allows users to upload 20,000 songs into the cloud, compared with Amazon Cloud Drive's 2,000 songs and 5 GB limit for free accounts.Any web-connected devices with a browser or supporting Flash can stream music from the digital locker, but the service is only for Android-powered devices.Music Beta also gets Instant Mix, a similar intelligent feature to Apple's Genius playlist creator, which creates new playlists based on a single song by analyzing its characteristics.Before unveiling the service, Google told U.S. media Monday night that the current Music Beta is not the service Google had wanted to offer and it will continue to seek licenses with major music labels.

MOSCOW, May 13 (Xinhua) -- The main and backup crews that will fly to the International Space Station in June have passed preflight tests and are ready for space travel, the Russian Cosmonauts Training Center said Friday.The main crew includes Russian cosmonaut Sergei Volkov, Japanese astronaut Satoshi Furukawa and American astronaut Michael Fossuma.A Russian spaceship Soyuz TMA-02M will send the crew to the space station on June 8, Interfax news agency reported.The backup crew includes members from Russia, the Netherlands and the United States.The crews were tested on the various emergency situations they could face during the flight.Next Monday, the commission will make a final choice of crewmembers for the launch.The crew will spend 161 days in orbit and conduct three space walks.

WASHINGTON, March 9 (Xinhua) -- U.S. space shuttle Discovery landed safely at the Kennedy Space Center in Florida on Wednesday, ending its nearly 27-year flying career as the world's most- traveled spaceship.According to NASA, Discovery touched down at 11:57 a.m. EST ( 1657 GMT) after a 13-day resupply mission to the International Space Station (ISS)."For the final time: wheels stop," Discovery's commander Steven Lindsey called out as the shuttle rolled to a full stop.Discovery lifted off on Feb. 24 from the Kennedy Center and arrived at the space station on Feb. 26.During the mission, the astronauts installed a spare closet module on the space station, completed some important repairs and delivered the first humanoid robot, though it will need more time to be assembled and made operational.The 330-pound R2 consists of a head and a torso with two arms and two hands. Once it is unpacked -- likely several months after its arrival at the station -- it will initially be operated inside the Destiny laboratory for operational testing, but over time both its territory and its applications could expand.Aboard the station, its primary job for now is teaching engineers how dexterous robots behave in space. However, the hope is that through upgrades and advancements, it could one day venture outside the station to help spacewalkers make repairs or additions to the station or perform scientific work.

BEIJING, March 11 (Xinhuanet) --Women who have a cup or more of coffee everyday may reduce their risk of stroke by as much as 25 percent, according to a new study in the Journal Stroke Thursday. This study, led by Swedish researcher Susanna Larsson of the Karolinska Institute in Stockholm, followed more than 34,000 Swedish women aged 49 to 83 who were free of heart disease. After 10-year of follow-up, there were 1,680 strokes, and the study found that those who drank at least one cup of coffee each day had a 22 to 25 percent lowered risk of stroke, compared with women who drank less.The study further suggested coffee can help prevent cognitive decline and can boost vision and heart health. It is also related to a reduced risk of liver cancer."We used to worry that (coffee) raises blood pressure and causes increased heart rate, but it appears to be less risky than we thought," said physician Claudette Brooks, spokesperson for the American Stroke Association. Now, exactly what it is about coffee that may lower stroke risk is unknown. But the researchers speculated that coffee might reduce inflammation, lower oxidative stress and help make the body more responsive to insulin.However, some experts kept skeptical about the real impact coffee would have on reducing the incidence of stroke."The problem with this type of study is that there are too many factors unaccounted for and association does not prove causality," Dr Larry B. Goldstein, director of the Duke Stroke Center at Duke University Medical Center said."Subjects were asked about their past coffee consumption in a questionnaire and then followed over time. There is no way to know if they changed their behavior," Goldstein added.In any case, the good news for coffee junkies is that at least drinking coffee don't increase women's risk of stroke.